Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
India GLP-1 Receptor Agonists Obesity Drugs Market Insight The India GLP-1 receptor agonists obesity drugs accounted for the largest revenue share in Asia Pacific in 2024, driven by a growing obesity burden, increasing healthcare awareness, and the rapid expansion of urban healthcare infrastructure
* Correspondence: Gilda Sandri, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
In mice with acute myocardial infarction, liraglutide treatment decreased atrial IL6 expression and circulating IL-6 levels
Tyrosinase is an enzyme that catalyzes the biosynthesis of melanin which is a culprit for skin darkening
US$ 24.30
US$ 23.17
US$ 25.93
US$ 26.56
US$ 22.69
US$ 27.88
